PHAR vs GERN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

PHAR

30.9
AI Score
VS
GERN Wins

GERN

56.4
AI Score

Investment Advisor Scores

PHAR

31score
Recommendation
EXTENDED

GERN

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR GERN Winner
Forward P/E 243.9024 49.2611 GERN
PEG Ratio 0 -2.38 Tie
Revenue Growth 20.8% 27.4% GERN
Earnings Growth 74.9% 0.0% PHAR
Tradestie Score 30.9/100 56.4/100 GERN
Profit Margin 6.2% -22.0% PHAR
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

PHAR 1M: +41.9% · 3M: +8.5% GERN 1M: -15.0% · 3M: -33.6%

Current Technical Phase

PHAR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 73.1 · Price: $13.40

GERN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.6%), weak momentum, RSI 44

RSI (14): 44.5 · Price: $1.02

Fundamentals Snapshot

Metric PHAR GERN
Market Cap — —
Forward P/E 74.4 11.3
Trailing P/E 41.3 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.3%
Gross Margin 0.9% 0.6%
Operating Margin 0.3% 0.1%
EPS 0.32 -0.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GERN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.